Letters

I feel compelled to respond to Ann Brierly’s letter (THE SCIENTIST, June 1, 1987, P. 10) about my Opinion article “Should Journals Pay Referees?” (THE SCIENTIST, March 9, 1987, p. 13). I agree with Brierly’s statement that reviewing manuscripts for journals is our professional duty, but thinking that being paid for reviewing a paper is a bribe is quite unreasonable. One of the professional duties of a physician is occasionally to examine people before they are hired for

Written byLeon J. Spicer
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

I feel compelled to respond to Ann Brierly’s letter (THE SCIENTIST, June 1, 1987, P. 10) about my Opinion article “Should Journals Pay Referees?” (THE SCIENTIST, March 9, 1987, p. 13). I agree with Brierly’s statement that reviewing manuscripts for journals is our professional duty, but thinking that being paid for reviewing a paper is a bribe is quite unreasonable. One of the professional duties of a physician is occasionally to examine people before they are hired for certain jobs. If the patient is found healthy and physically fit, is payment to the physician for services rendered considered a bribe?

If Brierly does not think referee apathy exists, she is kidding herself. Of the eight articles I published in four different refereed journals last year, only one set of reviews was sent hack to me within five weeks (from date of receipt at the editorial office to date of the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies